Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease from fatty accumulation
(steatosis), necro-inflammation though to fibrosis. It is of increasing global prevalence as a …

The prevalence of nonalcoholic fatty liver disease (NAFLD), one of the most common
chronic liver diseases worldwide, has been increasing. In terms of pathological changes …

Rationale and Objectives Marked liver steatosis, steatohepatitis, and significant fibrosis are
risk factors for unfavorable outcomes in non-alcoholic fatty liver disease (NAFLD). In this …

Abstract Background and Aims There remains a need to develop a non‐invasive, accurate
and easy‐to‐use tool to identify patients with non‐alcoholic steatohepatitis (NASH) …

Objectives Despite its widespread use there is no consensus on ultrasound criteria to
diagnose fatty liver. Method In an ongoing, cohort-study, participants were initially screened …

Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to NAFLD-related
liver cirrhosis and is a main cause of chronic liver diseases. Patients with nonalcoholic …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease.
Patients can be characterized on the NAFLD spectrum by the progressive presence of …

Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …

Rationale and Objectives To evaluate the performance of attenuation imaging (ATI) based
on ultrasound for detection of hepatic steatosis in patients with nonalcoholic fatty liver …

Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …